首页> 外文期刊>Radiation Research: Official Organ of the Radiation Research Society >Mechanisms Involved in the Development of the Chronic Gastrointestinal Syndrome in Nonhuman Primates after Total-Body Irradiation with Bone Marrow Shielding
【24h】

Mechanisms Involved in the Development of the Chronic Gastrointestinal Syndrome in Nonhuman Primates after Total-Body Irradiation with Bone Marrow Shielding

机译:非人体灵长类动物全身照射与骨髓屏蔽后在非人类灵长类动物中发展慢性胃肠综合征的机制。

获取原文
获取原文并翻译 | 示例
       

摘要

In this study, nonhuman primates (NHPs) exposed to lethal doses of total body irradiation (TBI) within the gastrointestinal (GI) acute radiation syndrome range, sparing; 5% of bone marrow (TBI-BM5), were used to evaluate the mechanisms involved in development of the chronic GI syndrome. TBI increased mucosal permeability in the jejunum (12-14 Gy) and proximal colon (13-14 Gy). TBI-BM5 also impaired mucosal barrier function at doses ranging from 10-12.5 Gy in both small intestine and colon. Timed necropsies of NHPs at 6-180 days after 10 Gy TBIBM5 showed that changes in small intestine preceded those in the colon. Chronic GI syndrome in NHPs is characterized by continued weight loss and intermittent GI syndrome symptoms. There was a long-lasting decrease in jejunal glucose absorption coincident with reduced expression of the sodium-linked glucose transporter. The small intestine and colon showed a modest upregulation of several different pro-inflammatory mediators such as NOS-2. The persistent inflammation in the post-TBI-BM5 period was associated with a long-lasting impairment of mucosal restitution and a reduced expression of intestinal and serum levels of alkaline phosphatase (ALP). Mucosal healing in the postirradiation period is dependent on sparing of stem cell crypts and maturation of crypt cells into appropriate phenotypes. At 30 days after 10 Gy TBI-BM5, there was a significant downregulation in the gene and protein expression of the stem cell marker Lgr5 but no change in the gene expression of enterocyte or enteroendocrine lineage markers. These data indicate that even a threshold dose of 10 Gy TBI-BM5 induces a persistent impairment of both mucosal barrier function and restitution in the GI tract and that ALP may serve as a biomarker for these events. These findings have important therapeutic implications for the design of medical countermeasures. (C) 2016 by Radiation Research Society
机译:在这项研究中,非人灵长类动物(NHPs)在胃肠道(GI)急性放射综合症范围内暴露于致死剂量的全身辐射(TBI); 5%的骨髓(TBI-BM5)用于评估参与慢性GI综合征发展的机制。 TBI增加了空肠(12-14 Gy)和近端结肠(13-14 Gy)的粘膜通透性。在小肠和结肠中,TBI-BM5在10-12.5 Gy的剂量范围内也会损害粘膜屏障功能。 10 Gy TBIBM5后6-180天的NHP定时尸检显示,小肠的变化先于结肠的变化。 NHPs的慢性GI综合征的特征是持续体重减轻和间歇性GI综合征症状。空肠葡萄糖吸收长期持续下降,同时钠连接的葡萄糖转运蛋白表达降低。小肠和结肠显示出几种不同的促炎性介质(例如NOS-2)的适度上调。 TBI-BM5后时期的持续炎症与粘膜恢复的长期损害以及肠道和血清碱性磷酸酶(ALP)的表达降低有关。照射后的粘膜愈合取决于干细胞隐窝的保留和隐窝细胞成熟为适当的表型。 10 Gy TBI-BM5后30天,干细胞标记Lgr5的基因和蛋白质表达显着下调,但肠上皮细胞或肠内分泌谱系标记的基因表达没有变化。这些数据表明,即使阈值剂量为10 Gy TBI-BM5,也会在胃肠道中引起粘膜屏障功能和恢复的持续损害,并且ALP可能充当这些事件的生物标志物。这些发现对医疗对策的设计具有重要的治疗意义。 (C)放射研究学会2016年

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号